Mixed Chimerism-Based Regimens in VCA

被引:0
|
作者
Lellouch A.G. [1 ,2 ]
Ng Z.Y. [1 ,2 ]
Kurtz J.M. [2 ,3 ]
Cetrulo C.L., Jr. [1 ,2 ]
机构
[1] Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA
[2] Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA
[3] Department of Biology, Emmanuel College, Boston, MA
关键词
Bone marrow; Mixed chimerism; Transplant tolerance; Vascularized composite allograft;
D O I
10.1007/s40472-016-0124-7
中图分类号
学科分类号
摘要
Amputations and devastating injuries throughout the body can now be reconstructed by transplanting vascularized composite allografts (VCAs) of the extremities, face, penis, scalp, skull, abdominal wall, and even the uterus. While functional and quality of life outcomes have been highly promising, the requirement for, and complications from long-term immunosuppression have predictably been reported in VCA recipients as with solid organ transplantation. Immunologic tolerance represents an alternative strategy to prevent rejection of VCAs without the need for immunosuppression. Clinically, long-term tolerance of allografts without maintenance immunosuppression has been achieved in kidney transplantation patients through the induction of mixed chimerism, whereby both donor and recipient-derived lymphohematopoietic elements co-exist within the recipient. This paper serves to review the currently available evidence from both clinical and experimental studies on mixed chimerism based regimens in VCA. © 2016, Springer International Publishing AG.
引用
收藏
页码:390 / 394
页数:4
相关论文
共 50 条
  • [31] Absent mRNA Accumulation of Th1 or Th2 Cytokines in Heart Allografts with Chimerism-Based Drug-Induced Tolerance
    Yukihiro Tomita
    Qi-Wei Zhang
    Goro Matsuzaki
    Ichiro Shimizu
    Toshiro Iwai
    Shinji Okano
    Kikuo Nomoto
    Hisataka Yasui
    Surgery Today, 2005, 35 : 364 - 370
  • [32] MIXED CHIMERISM AND TRANSPLANTATION TOLERANCE
    SACHS, DH
    SHARABI, Y
    SYKES, M
    PROGRESS IN IMMUNOLOGY, VOL 7, 1989, : 1171 - 1176
  • [33] CHIMERISM TESTING WITH REDUCED INTENSITY INTRAVENOUS BUSULFAN-BASED CONDITIONING REGIMENS: ONCE IS ENOUGH
    Bredeson, C.
    Burkart, Y.
    Zhu, X.
    Sun, Y.
    LeRademacher, J.
    Pasquini, M.
    Armstrong, E.
    Rizzo, J. D.
    Kato, K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S331 - S332
  • [34] Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies
    Horn, Biljana
    Petrovic, Aleksandra
    Wahlstrom, Justin
    Dvorak, Christopher C.
    Kong, Denice
    Hwang, Jimmy
    Expose-Spencer, Jueleah
    Gates, Michael
    Cowen, Morton J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) : 729 - 737
  • [35] Transplantation tolerance induced by mixed chimerism
    Wekerle, T
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (08): : 816 - 823
  • [36] Mixed chimerism: From allo to xeno
    Sachs, David H.
    XENOTRANSPLANTATION, 2017, 24 (05)
  • [37] Mixed hematopoietic chimerism and transplantation tolerance
    Boris Nikolic
    Megan Sykes
    Immunologic Research, 1997, 16 : 217 - 228
  • [38] Mixed hematopoietic chimerism and tolerance.
    Sykes, M
    Ohdan, H
    Wekerle, T
    Yang, YG
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 799 - 799
  • [39] Induction of mixed allogeneic chimerism for leukemia
    Seledtsov, VI
    Seledtsova, GV
    Avdeev, EV
    Samarin, DM
    Kozlov, VA
    LEUKEMIA RESEARCH, 1997, 21 (10) : 907 - 909
  • [40] Induction of Tolerance through Mixed Chimerism
    Sachs, David H.
    Kawai, Tatsuo
    Sykes, Megan
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2014, 4 (01):